U01CA244303
Cooperative Agreement
Overview
Grant Description
Role of O-Glcnacome on breast cancer initiating cells
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Philadelphia,
Pennsylvania
19102
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 420% from $575,137 to $2,989,507.
Drexel University was awarded
Role of O-GlcNAcome on Breast Cancer Initiating Cells
Cooperative Agreement U01CA244303
worth $2,989,507
from National Cancer Institute in March 2020 with work to be completed primarily in Philadelphia Pennsylvania United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.396 Cancer Biology Research.
The Cooperative Agreement was awarded through grant opportunity Alliance of Glycobiologists for Cancer Research: Biological Tumor Glycomics Laboratories (U01).
Status
(Complete)
Last Modified 5/6/24
Period of Performance
3/1/20
Start Date
2/28/25
End Date
Funding Split
$3.0M
Federal Obligation
$0.0
Non-Federal Obligation
$3.0M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U01CA244303
Transaction History
Modifications to U01CA244303
Additional Detail
Award ID FAIN
U01CA244303
SAI Number
U01CA244303-2593883013
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
XF3XM9642N96
Awardee CAGE
1JDU4
Performance District
PA-03
Senators
Robert Casey
John Fetterman
John Fetterman
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,821,236 | 100% |
Modified: 5/6/24